PRLD vs TAP
Prelude Therapeutics Inc (PRLD) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
TAP (TAP) common stock.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
TAP does not have a complete income-statement cache yet.
PRLD currently screens at market cap $346.5M. TAP currently screens at market cap $0.
Not investment advice. Open the PRLD and TAP stock pages for the full models.
Not investment advice.